Starry(SH:603520) Xin Lang Cai Jing·2025-11-13 02:52Group 1 - The core viewpoint of the news is that Sitaly Pharmaceutical has experienced a significant stock price increase, with a 5.31% rise on November 13, reaching 12.30 CNY per share, and a total market capitalization of 5.392 billion CNY [1] - Sitaly Pharmaceutical's stock has risen for four consecutive days, with a cumulative increase of 11.24% during this period [1] - The company specializes in the production and sales of X-ray non-ionic iodine contrast agent raw materials and quinolone raw materials, with the main business revenue composition being 79.73% from contrast agents, 10.19% from other supplementary products, and 1.52% from quinolone series [1] Group 2 - Among the top ten circulating shareholders of Sitaly Pharmaceutical, Penghua Fund's Penghua Medical Technology Stock A (001230) has recently entered the list, holding 4.6163 million shares, which accounts for 1.05% of the circulating shares [2] - During the four-day stock price increase, the floating profit for Penghua Medical Technology Stock A is approximately 544.72 thousand CNY [2] - The fund has achieved a year-to-date return of 77.51% and ranks 53rd out of 4216 in its category [2]